Schedule 13G ownership disclosure
ANIKA THERAPEUTICS INC
Common Stock · CUSIP: 035255108
Event date: 2025-03-31
- Filing-level shares
- 963,078
- Percent of class
- 6.8%
- BlackRock, Inc.
Shares: 963,078 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001576419-25-000696
- Form type
- SCHEDULE 13G/A
- Filer
- Anika Therapeutics, Inc.
- CIK
- CIK 898437
- Filed
- Apr 17, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership